1 |
Desantis C, Melissa M, Rebecca S, Ahmedin J (2009). Breast cancer facts and figures 2009-2010. In, (Atlanta, Georgia.: American Cancer Society, Inc.), pp. 1-38.
|
2 |
Freshney RI (2010). Culture of animal cells: A manual of basic technique and specialized application, 6th edn (Canada: John WIley & Sons, Inc.).
|
3 |
Gwyther SJ, Schwartz LH (2008). How to assess anti-tumour efficacy by imaging techniques. Eur J Cancer, 44, 39-45.
DOI
ScienceOn
|
4 |
Hale LP, Greer PK, Trinh CT, Gottfried MR (2005a). Treatment with oral bromelain decreases colonic inflammation in the il-10-deficient murine model of inflammatory bowel disease. Clin Immunol, 116, 135-42.
DOI
ScienceOn
|
5 |
Hale LP, Greer PK, Trinh CT, James CL (2005b). Proteinase activity and stability of natural bromelain preparations. Int Immunopharmacol, 5, 783-93.
DOI
ScienceOn
|
6 |
Iwata K, Kawasaki K, Shigesada N (2000). A dynamical model for the growth and size distribution of multiple metastatic tumors. J Theor Biol, 203, 177-86.
DOI
ScienceOn
|
7 |
Koblinski JE, Ahram M, Sloane BF (2000). Unraveling the role of proteases in cancer. Clin Chim Acta, 291, 113-35.
DOI
ScienceOn
|
8 |
Lednicer D, Narayanan VL (1993). Acquisation and screening of natural products as potential anticancer and aids antiviral agents, (Boca Raton: CRC Press, Inc.).
|
9 |
Manhart N, Akomeah R, Bergmeister H, et al (2002). Administration of proteolytic enzymes bromelain and trypsin diminish the number of cd4+ cells and the interferon-gamma response in peyer’s patches and spleen in endotoxemic balb/c mice. Cell Immunol, 215, 113-9.
DOI
ScienceOn
|
10 |
Maurer HR (2001). Bromelain: Biochemistry, pharmacology and medical use. Cell Mol Life Sci, 58, 1234-45.
DOI
ScienceOn
|
11 |
Mehrara E, Forssell-Aronsson E, Ahlman H, Bernhardt P (2007). Specific growth rate versus doubling time for quantitative characterization of tumor growth rate. Cancer Res, 67, 3970-5.
DOI
ScienceOn
|
12 |
Michaelis LC, Ratain MJ (2006). Measuring response in a post-recist world: From black and white to shades of grey. Nat Rev Cancer, 6, 409-14.
DOI
ScienceOn
|
13 |
Mosley CA, Liotta DC, Snyder JP (2007). Highly active anticancer curcumin analogues. Adv Exp Med Biol, 595, 77-103.
DOI
|
14 |
O’Reilly MS, Boehm T, Shing Y, et al (1997). Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell, 88, 277-85.
DOI
ScienceOn
|
15 |
Saville MW, Lietzau J, Pluda JM et al (1995). Treatment of hiv-associated kaposi's sarcoma with paclitaxel. Lancet, 346, 26-8.
DOI
ScienceOn
|
16 |
Society AC (2013). Cancer prevention and early detection facts and figures 2013. In, (Atlanta: AMerican Cancer Society).
|
17 |
Tysnes BB, Maurer HR, Porwol T, et al (2001). Bromelain reversibly inhibits invasive properties of glioma cells. Neoplasia, 3, 469-79.
DOI
|
18 |
Zavadova E, Desser L, Mohr T (1995). Stimulation of reactive oxygen species production and cytotoxicity in human neutrophils in vitro and after oral administration of a polyenzyme preparation. Cancer Biother, 10, 147-52.
DOI
ScienceOn
|
19 |
Amid A, Ismail NA, Yusof F, Salleh HM (2011). Expression, purification, and characterization of a recombinant stem bromelain from ananas comosus. Process Biochem, 46, 2232-9.
DOI
ScienceOn
|
20 |
Afenya EK, Calderon CP (2000). Diverse ideas on the growth kinetics of disseminated cancer cells. Bull Math Biol, 62, 527-42.
DOI
ScienceOn
|
21 |
Bajzer Z (1999). Gompertzian growth as a self-similar and allometric process. Growth Dev Aging, 63, 3-11.
|
22 |
Bala M, Salleh HM, Amid A, et al (2011). Recovery of recombinant bromelain from escherichia coli bl21-ai. Afr J Biotechnol, 10, 18829-32.
|
23 |
Castell JV (1995). Intestinal absorption of undegraded bromelain in humans, (Berlin: Springer Berlin Heidelberg).
|
24 |
Chik WDW, Amid A, and Jamal P (2010). Purification and cytotoxicity assay of tomato (lycopersicon esculen tum) leaves methanol extract as potential anticancer agent. J App Sci, 10, 3283-8.
DOI
|
25 |
Chobotova K, Vernallis AB, Majid FA (2010). Bromelain's activity and potential as an anti-cancer agent: Current evidence and perspectives. Cancer Lett, 290, 148-56.
DOI
ScienceOn
|
26 |
Dang C, Gilewski TA, Surbone A, Norton L (2003). Cytokinetics, (Rockville Pike: BC Decker Inc).
|
27 |
Deasy BM, Jankowski RJ, Payne TR, et al (2003). Modeling stem cell population growth: Incorporating terms for proliferative heterogeneity. Stem Cells, 21, 536-45.
DOI
ScienceOn
|